tiprankstipranks
89bio (ETNB)
NASDAQ:ETNB
US Market

89bio (ETNB) Income Statement

Compare
874 Followers

89bio Income Statement

Last quarter (Q4 2024), 89bio's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, 89bio's net income was $-118.35M. See 89bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -273.00K$ -240.00K$ -79.00K$ -60.00K
Operating Expenses
$ 384.66M$ 151.20M$ 102.25M$ 89.74M$ 49.35M
Depreciation and Amortization
$ 0.00$ 273.00K$ 240.00K$ 79.00K$ 60.00K
EBITDA
$ -384.66M$ -134.46M$ -99.84M$ -90.19M$ -49.50M
Operating Income
$ -384.66M$ -151.20M$ 102.25M$ -89.74M$ -49.35M
Other Income/Expenses
$ 18.27M$ 12.88M$ 242.00K$ -526.00K$ -203.00K
Pretax Income
$ -366.39M$ -138.32M$ -102.01M$ -90.27M$ -49.56M
Net Income
$ -367.08M$ -142.19M$ -102.03M$ -90.12M$ -49.50M
Per Share Metrics
Basic EPS
$ -3.51$ -2.00$ -2.93$ -4.48$ -3.08
Diluted EPS
$ -3.51$ -2.00$ -2.93$ -4.48$ -3.08
Weighted Average Shares Outstanding
104.71M 71.17M 34.81M 20.10M 16.09M
Weighted Average Shares Outstanding (Diluted)
104.71M 71.17M 34.81M 20.10M 16.09M
Currency in USD

89bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis